| 标题 |
A multicenter, phase 1/2 trial of anastrozole, palbociclib, trastuzumab, and pertuzumab in hormone receptor–positive, HER2-positive metastatic breast cancer (ASPIRE) |
| 网址 | |
| DOI |
10.1093/jnci/djag256
doi
|
| 其它 |
期刊:JNCI: Journal of the National Cancer Institute 作者:Rima Patel; Maryann Kwa; Paula Klein; Julie Fasano; Erin Moshier; et al 出版日期:2026-07-30 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)